The Ministry of Industry and Trade of the Russian Federation did not see a significant problem in the fact that the American pharmaceutical company Baxter, a supplier of dialysis solutions, suspended its commercial activities in Russia due to sanctions and logistical issues in the United States and Europe. The department pays special attention to the development of domestic production of solutions for these purposes, TASS reports, citing the ministry’s press service.
For example, preparations for peritoneal dialysis “Diasol PD” have already been registered, and the preparation “Diasolushn” was previously approved. The manufacturer is LLC “IST-PHARM” (part of the PharmaSintez Group). In January 2024, such preparations were repeatedly introduced into civil circulation. In the future, it is planned to meet the needs of the Russian healthcare system in this direction, promised the Ministry of Industry and Trade.
“Russian patients with kidney diseases have access to various types of dialysis (a form of renal replacement therapy) – peritoneal dialysis, hemodialysis, acute dialysis. <…> We pay special attention to the development of domestic production of dialysis solutions,” the department added.
Source: GxP news, April 11, 2024.
